This statistic displays annual revenue figures of the brand name pharmaceutical manufacturing industry in the United States from 2008 to 2013. In 2008, the revenue of brand name pharmaceutical manufacturing in the U.S. ranged at around 178 billion U.S. dollars.
Revenue of brand name pharmaceutical manufacturing (NAICS 32541a) in the United States from 2008 to 2013 (in billion U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Metabolic & digestive pharmaceuticals revenue in Argentina 2017-2022
- Premium Statistic Argentina: nervous system pharmaceuticals revenue 2017-2019
- Premium Statistic Genitourinary system & sexual hormones market revenue in Argentina 2017-2022
- Premium Statistic Pharmaceutical industry revenue in Argentina 2021, by target
- Premium Statistic Argentina: systemic anti-infective pharmaceuticals revenue 2017-2019
- Premium Statistic Research and development in European pharmaceutical industry by country 2021
- Basic Statistic Leading pharmaceutical companies in Denmark 2022, by revenue
- Premium Statistic Dermatological products market revenue in Argentina 2017-2022
- Basic Statistic Net sales of Recipharm 2009-2022
- Basic Statistic Gross profit of Sobi 2009-2023
About the region
10
- Basic Statistic Price disparities for top product Xarelto - U.S. and international 2024
- Basic Statistic Price disparities for top product Advair Diskus U.S. vs international 2024
- Premium Statistic Price disparities for top product Januvia U.S. vs international 2024
- Basic Statistic Price disparities for Spiriva Handihaler - U.S. and international 2024
- Basic Statistic Price disparities for top product Symbicort - U.S. and international 2024
- Basic Statistic Price disparities for top product Viagra - U.S. and international 2024
- Basic Statistic Percentage of active U.S. drug shortages in top therapeutic classes June 2023
- Basic Statistic Disparities median price Lantus by select countries 2019
- Basic Statistic Retail price increase of geriatric drugs in the U.S. in 2020, by manufacturer
- Premium Statistic Number of total approvals by top pharmaceutical companies 2017
Selected statistics
10
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
Other regions
10
- Basic Statistic Market share of generics in European countries 2021
- Premium Statistic Industry turnover for leading pharmaceuticals German 2017
- Basic Statistic Annual revenue of Sobi 2009-2023
- Premium Statistic Colombia: top drug store chains in 2017. by size
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Mexico: pharmaceutical expenditure 2012-2018
- Premium Statistic Latin America: per capita sales of OTC medicines 2017, by country
- Premium Statistic Revenue of the pharmaceutical company Bracco 2020, by geographical area
- Basic Statistic Sales volume pharmaceuticals in Norway by drug category 2022
- Basic Statistic Number of NAS approved by Health Canada 2014-2021
Related statistics
10
- Premium Statistic Revenue of ready-mix concrete manufacturing in the U.S., 2009-2021
- Premium Statistic Revenue of dairy wholesaling in the U.S., 2008-2020
- Premium Statistic Revenue of oil drilling & gas extraction in the U.S., 2009-2014
- Premium Statistic Revenue of civic, social & youth organizations in the U.S., 2009-2014
- Premium Statistic Revenue of laundromats in the U.S., 2009-2014
- Premium Statistic Revenue of for-profit universities in the U.S., 2009-2014
- Premium Statistic Revenue of electric power transmission in the U.S., 2009-2014
- Premium Statistic Revenue of mineral & phosphate mining in the U.S., 2009-2014
- Premium Statistic Revenue of loan brokers in the U.S., 2009-2014
- Premium Statistic Revenue of real estate asset management & consulting in the U.S., 2009-2014
Further related statistics
10
- Pfizer's ad spending 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Ping An Insurance's annual revenue 2012-2022
- Net revenue from investment banking at Goldman Sachs 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Ping An Insurance's annual revenue 2012-2022
- Net revenue from investment banking at Goldman Sachs 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
Statista. (December 31, 2013). Revenue of brand name pharmaceutical manufacturing (NAICS 32541a) in the United States from 2008 to 2013 (in billion U.S. dollars) [Graph]. In Statista. Retrieved April 26, 2024, from https://www.statista.com/statistics/291203/revenue-of-brand-name-pharmaceutical-manufacturing-in-the-us/
Statista. "Revenue of brand name pharmaceutical manufacturing (NAICS 32541a) in the United States from 2008 to 2013 (in billion U.S. dollars)." Chart. December 31, 2013. Statista. Accessed April 26, 2024. https://www.statista.com/statistics/291203/revenue-of-brand-name-pharmaceutical-manufacturing-in-the-us/
Statista. (2013). Revenue of brand name pharmaceutical manufacturing (NAICS 32541a) in the United States from 2008 to 2013 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: April 26, 2024. https://www.statista.com/statistics/291203/revenue-of-brand-name-pharmaceutical-manufacturing-in-the-us/
Statista. "Revenue of Brand Name Pharmaceutical Manufacturing (Naics 32541a) in The United States from 2008 to 2013 (in Billion U.S. Dollars)." Statista, Statista Inc., 31 Dec 2013, https://www.statista.com/statistics/291203/revenue-of-brand-name-pharmaceutical-manufacturing-in-the-us/
Statista, Revenue of brand name pharmaceutical manufacturing (NAICS 32541a) in the United States from 2008 to 2013 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/291203/revenue-of-brand-name-pharmaceutical-manufacturing-in-the-us/ (last visited April 26, 2024)
Revenue of brand name pharmaceutical manufacturing (NAICS 32541a) in the United States from 2008 to 2013 (in billion U.S. dollars) [Graph], Statista, December 31, 2013. [Online]. Available: https://www.statista.com/statistics/291203/revenue-of-brand-name-pharmaceutical-manufacturing-in-the-us/